Preliminary studies show conolidine might inhibit specific ion channels, lessening neuronal excitability and restricting suffering signals. This system is especially applicable in neuropathic soreness, where abnormal signaling triggers persistent pain. Moreover, conolidine appears to influence G protein-coupled receptor (GPCR) pathways integral to suffering perception. Computational d... https://alvaj258plf6.wikisona.com/user